Free Trial

OPKO Health (OPK) News Today

OPKO Health logo
$1.70 -0.04 (-2.30%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$1.72 +0.02 (+1.18%)
As of 03/28/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
OPKO Health, Inc. stock logo
Charles Schwab Investment Management Inc. Cuts Position in OPKO Health, Inc. (NASDAQ:OPK)
Charles Schwab Investment Management Inc. lowered its position in OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 17.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,497,406 shares of the biotechnology company's s
OPKO Health, Inc. stock logo
Zacks Research Weighs in on OPKO Health FY2027 Earnings
OPKO Health, Inc. (NASDAQ:OPK - Free Report) - Equities research analysts at Zacks Research issued their FY2027 earnings estimates for shares of OPKO Health in a research report issued to clients and investors on Thursday, March 20th. Zacks Research analyst R. Department anticipates that the biot
OPKO Health, Inc. stock logo
OPKO Health (NASDAQ:OPK) Given Buy Rating at HC Wainwright
HC Wainwright reiterated a "buy" rating and issued a $3.00 target price on shares of OPKO Health in a report on Wednesday.
OPKO Health, Inc. stock logo
Phillip Md Et Al Frost Purchases 200,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) Stock
OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost bought 200,000 shares of the company's stock in a transaction dated Monday, March 17th. The shares were acquired at an average cost of $1.74 per share, with a total value of $348,000.00. Following the acquisition, the chief executive officer now directly owns 213,501,448 shares of the company's stock, valued at approximately $371,492,519.52. This represents a 0.09 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Opko Health CEO buys $348K in common stock
OPKO Health, Inc. stock logo
Q2 Earnings Forecast for OPKO Health Issued By HC Wainwright
OPKO Health, Inc. (NASDAQ:OPK - Free Report) - HC Wainwright raised their Q2 2025 earnings per share (EPS) estimates for OPKO Health in a report issued on Wednesday, March 12th. HC Wainwright analyst Y. Chen now expects that the biotechnology company will post earnings of ($0.07) per share for th
OPKO Health, Inc. stock logo
Essential Planning LLC. Takes Position in OPKO Health, Inc. (NASDAQ:OPK)
Essential Planning LLC. acquired a new stake in OPKO Health, Inc. (NASDAQ:OPK - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 331,175 shares of the biotechnology company's stock, valued at approximately $506,000. A
OPKO Health, Inc. stock logo
OPKO Health (NASDAQ:OPK) Receives Buy Rating from HC Wainwright
HC Wainwright reaffirmed a "buy" rating and issued a $3.00 price objective on shares of OPKO Health in a research note on Wednesday.
OPKO Health, Inc. stock logo
Barrington Research Reaffirms Outperform Rating for OPKO Health (NASDAQ:OPK)
Barrington Research reaffirmed an "outperform" rating and set a $2.25 price target on shares of OPKO Health in a research report on Wednesday.
OPKO Health, Inc. stock logo
OPKO Health (NASDAQ:OPK) Shares Gap Up - Here's What Happened
OPKO Health (NASDAQ:OPK) Shares Gap Up - Here's What Happened
Labcorp, Opko Health acquire certain assets of BioReference Health
OPKO Health, Inc. stock logo
OPKO Health (NASDAQ:OPK) Shares Up 3.1% - What's Next?
OPKO Health (NASDAQ:OPK) Trading Up 3.1% - Should You Buy?
OPKO Health, Inc. stock logo
OPKO Health (NASDAQ:OPK) Hits New 1-Year High - Here's Why
OPKO Health (NASDAQ:OPK) Reaches New 52-Week High - Here's Why
OPKO Health, Inc. stock logo
OPKO Health (NASDAQ:OPK) Shares Up 3.1% - Here's What Happened
OPKO Health (NASDAQ:OPK) Trading 3.1% Higher - Should You Buy?
OPKO Health, Inc. stock logo
OPKO Health (NASDAQ:OPK) Rating Increased to Hold at StockNews.com
StockNews.com upgraded OPKO Health from a "sell" rating to a "hold" rating in a research report on Monday.
OPKO Health, Inc. stock logo
Barrington Research Reaffirms "Outperform" Rating for OPKO Health (NASDAQ:OPK)
Barrington Research restated an "outperform" rating and issued a $2.25 target price on shares of OPKO Health in a research note on Friday.
OPKO Health, Inc. stock logo
OPKO Health (NASDAQ:OPK) Reaches New 52-Week High on Strong Earnings
OPKO Health (NASDAQ:OPK) Reaches New 1-Year High After Better-Than-Expected Earnings
OPKO Health, Inc. stock logo
Phillip Md Et Al Frost Acquires 67,434 Shares of OPKO Health, Inc. (NASDAQ:OPK) Stock
OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost acquired 67,434 shares of the stock in a transaction dated Friday, February 28th. The stock was acquired at an average cost of $1.71 per share, with a total value of $115,312.14. Following the transaction, the chief executive officer now owns 213,301,448 shares of the company's stock, valued at approximately $364,745,476.08. This trade represents a 0.03 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
OPKO Health, Inc. stock logo
OPKO Health (NASDAQ:OPK) Issues Quarterly Earnings Results, Beats Expectations By $0.09 EPS
OPKO Health (NASDAQ:OPK - Get Free Report) issued its quarterly earnings results on Thursday. The biotechnology company reported $0.01 EPS for the quarter, topping the consensus estimate of ($0.08) by $0.09. OPKO Health had a negative net margin of 18.65% and a negative return on equity of 9.76%.
OPKO Health, Inc. stock logo
OPKO Health (NASDAQ:OPK) Posts Quarterly Earnings Results, Beats Estimates By $0.09 EPS
OPKO Health (NASDAQ:OPK - Get Free Report) posted its earnings results on Thursday. The biotechnology company reported $0.01 earnings per share for the quarter, beating the consensus estimate of ($0.08) by $0.09. OPKO Health had a negative net margin of 18.65% and a negative return on equity of 9.76%.
OPKO Health, Inc. (OPK) Q4 2024 Earnings Call Transcript
Opko Health (OPK) Q4 2024 Earnings Call Transcript
OPKO Health, Inc. stock logo
OPKO Health (OPK) to Release Earnings on Thursday
OPKO Health (NASDAQ:OPK) will be releasing earnings after the market closes on Thursday, February 27, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=666426)
OPKO Health, Inc. stock logo
Investors Buy High Volume of Call Options on OPKO Health (NASDAQ:OPK)
OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) saw unusually large options trading activity on Monday. Investors bought 9,645 call options on the stock. This represents an increase of 402% compared to the average daily volume of 1,921 call options.
OPKO Health, Inc. stock logo
OPKO Health (OPK) to Release Earnings on Tuesday
OPKO Health (NASDAQ:OPK) will be releasing earnings after the market closes on Tuesday, February 25, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=666426)
OPKO Health, Inc. stock logo
Y.D. More Investments Ltd Sells 318,077 Shares of OPKO Health, Inc. (NASDAQ:OPK)
Y.D. More Investments Ltd decreased its position in OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 18.6% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 1,395,768 shares of the biotechnology company's stock after selling 318,077 shares du
OPKO Health, Inc. stock logo
OPKO Health (NASDAQ:OPK) Sees Strong Trading Volume - Should You Buy?
OPKO Health (NASDAQ:OPK) Sees Large Volume Increase - Still a Buy?
OPKO Health, Inc. stock logo
Phillip Md Et Al Frost Buys 47,537 Shares of OPKO Health, Inc. (NASDAQ:OPK) Stock
OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost acquired 47,537 shares of the stock in a transaction dated Tuesday, January 28th. The shares were bought at an average price of $1.47 per share, for a total transaction of $69,879.39. Following the transaction, the chief executive officer now owns 213,234,014 shares in the company, valued at approximately $313,454,000.58. This represents a 0.02 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
OPKO Health, Inc. stock logo
Assenagon Asset Management S.A. Sells 634,254 Shares of OPKO Health, Inc. (NASDAQ:OPK)
Assenagon Asset Management S.A. lessened its stake in shares of OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 42.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 856,738 shares of the biotechnology company's stock after selling 634,254 shares during
Remove Ads
Get OPKO Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for OPK and its competitors with MarketBeat's FREE daily newsletter.

Related Videos

3 Stocks That Wall Street Insiders Can’t Stop Buying

OPK Media Mentions By Week

OPK Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

OPK
News Sentiment

1.01

0.79

Average
Medical
News Sentiment

OPK News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

OPK Articles
This Week

8

4

OPK Articles
Average Week

Remove Ads
Get OPKO Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for OPK and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:OPK) was last updated on 3/29/2025 by MarketBeat.com Staff
From Our Partners